Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells

被引:64
|
作者
Lombardi, Maria [1 ]
Castoria, Gabriella [1 ]
Migliaccio, Antimo [1 ]
Barone, Maria Vittoria [2 ]
Di Stasio, Rosina [1 ]
Ciociola, Alessandra [1 ]
Bottero, Daniela [1 ]
Yamaguchi, Hiroshi [3 ]
Appella, Ettore [3 ]
Auricchio, Ferdinando [1 ]
机构
[1] Univ Naples 2, Dipartimento Patol Gen, I-80138 Naples, Italy
[2] Univ Naples Federico II, Dipartimento Pediat, European Lab Food Induced Dis, I-80131 Naples, Italy
[3] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
来源
JOURNAL OF CELL BIOLOGY | 2008年 / 182卷 / 02期
关键词
D O I
10.1083/jcb.200712125
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In breast cancer cells, cytoplasmic localization of the estradiol receptor alpha (ER alpha) regulates estradiol-dependent S phase entry. We identified a nuclear export sequence (NES) in ER alpha and show that its export is dependent on both estradiol-mediated phosphatidylinositol-3-kinase (PI3K)/AKT activation and chromosome region maintenance 1 (CRM1). A Tat peptide containing the ER alpha NES disrupts ER alpha-CRM1 interaction and prevents nuclear export of ER alpha- and estradiol-induced DNA synthesis. NES-ER alpha mutants do not exit the nucleus and inhibit estradiol-induced S phase entry; ER alpha-dependent transcription is normal. ER alpha is associated with Forkhead proteins in the nucleus, and estradiol stimulates nuclear exit of both proteins. ER alpha knockdown or ER alpha NES mutations prevent ER alpha and Forkhead nuclear export. A mutant of forkhead in rhabdomyosarcoma (FKHR), which cannot be phosphorylated by estradiol-activated AKT, does not associate with ER alpha and is trapped in the nucleus, blocking S phase entry. In conclusion, estradiol-induced AKT-dependent phosphorylation of FKHR drives its association with ER alpha, thereby triggering complex export from the nucleus necessary for initiation of DNA synthesis and S phase entry.
引用
收藏
页码:327 / 340
页数:14
相关论文
共 50 条
  • [31] New treatment options for hormone-dependent advanced breast cancer
    Wysocki, Piotr J.
    Potemski, Piotr
    Krzemieniecki, Krzysztof
    Wojtukiewicz, Marek
    Filipczyk-Cisarz, Emilia
    Drosik, Kazimierz
    Litwiniuk, Maria
    Jassem, Jacek
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2012, 8 (03): : 85 - 90
  • [32] Hormone-dependent placental manipulation of breast cancer cell migration
    Shochet, G. Epstein
    Matalon, S. Tartakover
    Drucker, L.
    Pomeranz, M.
    Fishman, A.
    Rashid, G.
    Oron-Karni, V.
    Pasmanik-Chor, M.
    Lishner, M.
    HUMAN REPRODUCTION, 2012, 27 (01) : 73 - 88
  • [33] CHANGING STRATEGIES IN THE TREATMENT OF HORMONE-DEPENDENT BREAST-CANCER
    DAO, TL
    SEMINARS IN SURGICAL ONCOLOGY, 1989, 5 (02): : 111 - 117
  • [34] New therapeutical strategies in metastatic hormone-dependent breast cancer
    Vilquin, Paul
    Cohen, Pascale
    Maudelonde, Thierry
    Tredan, Olivier
    Treilleux, Isabelle
    Bachelot, Thomas
    Heudel, Pierre-Etienne
    BULLETIN DU CANCER, 2015, 102 (04) : 367 - 380
  • [35] Adjuvant endocrine therapy options in hormone-dependent breast cancer
    Strasser-Weippl, K
    Goss, PE
    EJC SUPPLEMENTS, 2005, 3 (03): : 247 - 254
  • [36] Androgen receptor action in hormone-dependent and recurrent prostate cancer
    Agoulnik, Irina U.
    Weigel, Nancy L.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (02) : 362 - 372
  • [37] Cistromics of hormone-dependent cancer
    Lupien, Mathieu
    Brown, Myles
    ENDOCRINE-RELATED CANCER, 2009, 16 (02) : 381 - 389
  • [38] SELECTION OF HORMONE-DEPENDENT BREAST CANCERS
    HOBBS, JR
    DESOUZA, I
    SALIH, H
    RAGGATT, P
    BRITISH JOURNAL OF SURGERY, 1974, 61 (10) : 785 - 786
  • [39] Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells
    Nonclercq, Denis
    Journe, Fabrice
    Laios, Ioanna
    Chaboteaux, Carole
    Toillon, Robert-Alain
    Leclercq, Guy
    Laurent, Guy
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2007, 39 (1-2) : 105 - 118
  • [40] Synthesis, structure, docking and cytotoxic studies of ferrocene-hormone conjugates for hormone-dependent breast cancer application
    Carmona-Negron, Jose A.
    Santana, Alberto
    Rheingold, Arnold L.
    Melendez, Enrique
    DALTON TRANSACTIONS, 2019, 48 (18) : 5952 - 5964